25718

    531768

    POLYMED

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    POLY MEDICURE LIMITED Share Price Today

    POLY MEDICURE LIMITED is currently trading at ₹1667.6, down by ₹13.09 from the previous close. The stock touched an intraday high of ₹1679.60 and a low of ₹1662.10 during the latest trading session. Over the past one year, POLY MEDICURE LIMITED has delivered a loss of 14.65%, while the stock has gained 1.7% in the last one month.

    POLY MEDICURE LIMITED performance

    Today’s low Today’s high
    ₹ 1662.10 ₹ 1679.60
    ₹ 1663.80
    52 week low 52 week high
    ₹ 1182.00 ₹ 2144.90
    ₹ 1663.80
    Open Price ₹ 1670.10
    Prev. Close ₹ 1680.70
    Volume (Shares) 10416.00
    Total traded value ₹ 173.30
    Upper Circuit ₹ 2016.80
    Lower Circuit ₹ 1344.60
    info

    Investment Returns

    Over 1 Month 1.70% Over 3 Months 12.37% Over 6 Months 10.92% Over 1 Year -14.65%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    POLY MEDICURE LIMITED fundamentals


    • Market cap (Cr) 16,864.20
    • P/E Ratio (TTM) 50.67
    • Beta 0.90
    • Book Value / share 301.17
    • Return on equity 15.77%
    • EPS (TTM) 33.65
    • Dividend yield 0.21%
    • Net profit/quarter (Cr) 80.62
    info icon alternate text
    • Market cap (Cr) 16,935.70
    • P/E Ratio (TTM) 50.67
    • Beta 0.98
    • Book Value / share 301.17
    • Return on equity 15.77%
    • EPS (TTM) 33.65
    • Dividend yield 0.21%
    • Net profit/quarter (Cr) 80.62
    info icon alternate text

    POLY MEDICURE LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 443.01
    Operating Expense 351.33
    Net Profit 80.62
    Net Profit Margin (%) 18.19
    Earnings Per Share (EPS) 7.95
    EBITDA 136.21
    Effective Tax Rate (%) 24.51
    Particulars DEC 2025 (Values in Cr)
    Revenue 418.86
    Operating Expense 335.59
    Net Profit 78.38
    Net Profit Margin (%) 18.71
    Earnings Per Share (EPS) 7.73
    EBITDA 135.01
    Effective Tax Rate (%) 26.06
    Particulars SEP 2025 (Values in Cr)
    Revenue 416.54
    Operating Expense 332.25
    Net Profit 89.05
    Net Profit Margin (%) 21.37
    Earnings Per Share (EPS) 8.79
    EBITDA 144.94
    Effective Tax Rate (%) 24.54
    Particulars JUN 2025 (Values in Cr)
    Revenue 384.05
    Operating Expense 308.50
    Net Profit 87.93
    Net Profit Margin (%) 22.89
    Earnings Per Share (EPS) 8.68
    EBITDA 142.71
    Effective Tax Rate (%) 24.89
    Particulars MAR 2025 (Values in Cr)
    Revenue 420.97
    Operating Expense 328.43
    Net Profit 86.66
    Net Profit Margin (%) 20.58
    Earnings Per Share (EPS) 8.40
    EBITDA 140.00
    Effective Tax Rate (%) 25.61
    Particulars MAR 2026 (Values in Cr)
    Revenue 1662.46
    Operating Expense 1327.68
    Net Profit 335.98
    Net Profit Margin (%) 20.20
    Earnings Per Share (EPS) 33.15
    EBITDA 559.22
    Effective Tax Rate (%) 24.98
    Particulars MAR 2025 (Values in Cr)
    Revenue 1601.80
    Operating Expense 1248.68
    Net Profit 331.33
    Net Profit Margin (%) 20.68
    Earnings Per Share (EPS) 33.40
    EBITDA 535.14
    Effective Tax Rate (%) 25.18
    Particulars MAR 2024 (Values in Cr)
    Revenue 1307.25
    Operating Expense 1030.53
    Net Profit 251.72
    Net Profit Margin (%) 19.25
    Earnings Per Share (EPS) 26.24
    EBITDA 407.20
    Effective Tax Rate (%) 24.83
    Particulars MAR 2023 (Values in Cr)
    Revenue 1068.05
    Operating Expense 867.50
    Net Profit 179.04
    Net Profit Margin (%) 16.76
    Earnings Per Share (EPS) 18.67
    EBITDA 300.77
    Effective Tax Rate (%) 24.39
    Particulars MAR 2022 (Values in Cr)
    Revenue 879.36
    Operating Expense 723.37
    Net Profit 146.02
    Net Profit Margin (%) 16.60
    Earnings Per Share (EPS) 15.23
    EBITDA 250.87
    Effective Tax Rate (%) 25.01
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 272.95
    ROE % 15.99
    ROCE % 20.24
    Total Debt to Total Equity 0.08
    EBITDA Margin 32.91
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 153.18
    ROE % 19.05
    ROCE % 23.44
    Total Debt to Total Equity 0.12
    EBITDA Margin 30.62
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 129.41
    ROE % 15.39
    ROCE % 18.95
    Total Debt to Total Equity 0.12
    EBITDA Margin 27.40
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 113.40
    ROE % 14.27
    ROCE % 17.26
    Total Debt to Total Equity 0.13
    EBITDA Margin 27.66
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 100.71
    ROE % 19.40
    ROCE % 21.67
    Total Debt to Total Equity 0.25
    EBITDA Margin 30.29
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 270.83
    ROE % 15.77
    ROCE % 20.03
    Total Debt to Total Equity 0.08
    EBITDA Margin 33.54
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 151.95
    ROE % 18.70
    ROCE % 23.12
    Total Debt to Total Equity 0.11
    EBITDA Margin 31.31
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 128.63
    ROE % 15.49
    ROCE % 19.21
    Total Debt to Total Equity 0.11
    EBITDA Margin 28.34
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 112.30
    ROE % 14.38
    ROCE % 17.54
    Total Debt to Total Equity 0.12
    EBITDA Margin 28.73
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 99.50
    ROE % 18.72
    ROCE % 21.37
    Total Debt to Total Equity 0.23
    EBITDA Margin 30.73
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 151.34
    Total Assets 3192.45
    Total Liabilities 3192.45
    Total Equity 2765.65
    Share Outstanding 10
    Price to Book Ratio 8.28
    Return on Assets (%) 10.60
    Return on Capital (%) 11.5
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 146.85
    Total Assets 1858.67
    Total Liabilities 1858.67
    Total Equity 1470.05
    Share Outstanding 9
    Price to Book Ratio 10.46
    Return on Assets (%) 13.89
    Return on Capital (%) 15.75
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 183.06
    Total Assets 1577.20
    Total Liabilities 1577.20
    Total Equity 1241.62
    Share Outstanding 9
    Price to Book Ratio 7.41
    Return on Assets (%) 11.36
    Return on Capital (%) 12.92
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 15.43
    Total Assets 1376.83
    Total Liabilities 1376.83
    Total Equity 1087.48
    Share Outstanding 9
    Price to Book Ratio 8.45
    Return on Assets (%) 10.64
    Return on Capital (%) 12.08
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 29.56
    Total Assets 1223.73
    Total Liabilities 1223.73
    Total Equity 965.57
    Share Outstanding 9
    Price to Book Ratio 8.22
    Return on Assets (%) 11.10
    Return on Capital (%) 12.36
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 143.19
    Total Assets 3140.35
    Total Liabilities 3140.35
    Total Equity 2744.21
    Share Outstanding 10
    Price to Book Ratio 8.28
    Return on Assets (%) 10.55
    Return on Capital (%) 11.37
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 136.94
    Total Assets 1821.34
    Total Liabilities 1821.34
    Total Equity 1458.24
    Share Outstanding 9
    Price to Book Ratio 10.46
    Return on Assets (%) 13.82
    Return on Capital (%) 15.55
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 170.95
    Total Assets 1537.76
    Total Liabilities 1537.76
    Total Equity 1234.12
    Share Outstanding 9
    Price to Book Ratio 7.41
    Return on Assets (%) 11.64
    Return on Capital (%) 13.08
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 8.31
    Total Assets 1333.96
    Total Liabilities 1333.96
    Total Equity 1076.97
    Share Outstanding 9
    Price to Book Ratio 8.45
    Return on Assets (%) 10.94
    Return on Capital (%) 12.31
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 27.40
    Total Assets 1187.41
    Total Liabilities 1187.41
    Total Equity 954.00
    Share Outstanding 9
    Price to Book Ratio 8.22
    Return on Assets (%) 10.90
    Return on Capital (%) 12.4
    Particulars MAR 2025 (Values in Cr)
    Net Income 452.51
    Cash from Operations 332.83
    Cash from Investing -1194.27
    Cash from Financing 950.50
    Net change in Cash -3.35
    Free Cash Flow 663.85
    Particulars MAR 2024 (Values in Cr)
    Net Income 344.26
    Cash from Operations 340.38
    Cash from Investing -240.93
    Cash from Financing -20.15
    Net change in Cash 4.99
    Free Cash Flow 617.39
    Particulars MAR 2023 (Values in Cr)
    Net Income 237.49
    Cash from Operations 248.69
    Cash from Investing -179.01
    Cash from Financing -12.50
    Net change in Cash -0.69
    Free Cash Flow 487.96
    Particulars MAR 2022 (Values in Cr)
    Net Income 195.24
    Cash from Operations 170.92
    Cash from Investing -85.33
    Cash from Financing -35.33
    Net change in Cash 2.80
    Free Cash Flow 326.50
    Particulars MAR 2021 (Values in Cr)
    Net Income 180.05
    Cash from Operations 163.35
    Cash from Investing -435.58
    Cash from Financing 316.94
    Net change in Cash 0.09
    Free Cash Flow 258.48
    Particulars MAR 2025 (Values in Cr)
    Net Income 442.89
    Cash from Operations 325.66
    Cash from Investing -1191.16
    Cash from Financing 952.92
    Net change in Cash -1.59
    Free Cash Flow 650.65
    Particulars MAR 2024 (Values in Cr)
    Net Income 334.89
    Cash from Operations 329.84
    Cash from Investing -237.02
    Cash from Financing -17.31
    Net change in Cash 1.76
    Free Cash Flow 601.23
    Particulars MAR 2023 (Values in Cr)
    Net Income 236.82
    Cash from Operations 254.66
    Cash from Investing -189.18
    Cash from Financing -7.89
    Net change in Cash -0.25
    Free Cash Flow 492.12
    Particulars MAR 2022 (Values in Cr)
    Net Income 194.71
    Cash from Operations 173.12
    Cash from Investing -88.71
    Cash from Financing -39.71
    Net change in Cash -2.16
    Free Cash Flow 324.93
    Particulars MAR 2021 (Values in Cr)
    Net Income 173.38
    Cash from Operations 160.53
    Cash from Investing -434.41
    Cash from Financing 318.91
    Net change in Cash 0.90
    Free Cash Flow 254.49
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8843.00 65.00 13.42 127148.77 6680.00 9008.90
    FORTIS MALAR HOSPITALS LIMITED 50.05 22.65 2.73 93.80 40.75 76.00
    SHREE PACETRONIX LTD. 124.80 14.89 2.62 46.80 71.00 283.15
    TRANSGENE BIOTEK LTD. 2.95 0.00 2.66 22.35 1.83 5.17
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8843.00 84.69 12.76 127148.77 6680.00 9008.90
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 37.12 0.00 -9.03 27.73 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5858.50 26.22 4.85 6409.20 5010.00 6725.00

    POLY MEDICURE LIMITED shareholding pattern

    Holding
    15.93%
    62.41%
    5.56%
    16.07%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    POLY MEDICURE LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1663.80 -1.00 redarrow
    red-green-graph indicator
    8 Bearish
    8 Bullish
    • 5 Days 1672.40
    • 26 Days 1647.00
    • 10 Days 1674.30
    • 50 Days 1600.10
    • 12 Days 1673.10
    • 100 Days 1572.80
    • 20 Days 1660.10
    • 200 Days 1653.80
    1706.57 PIVOT
    First Support 1638.13 First Resistance 1749.13 Second Support 1595.57 Second Resistance 1817.57 Third Support 1527.13 Third Resistance 1860.13
    RSI 54.50 ADX 40.24 MACD 26.10 Williams % R -55.67 Commodity Channel Index (CCI) 74.26
    Date 2026-07-27 Week 40831.00 Same Day 37665.00 Month 49838.00
    1 Year 0.91 3 Year 0.81
    Over 1 Month
    1.70% down
    Over 1 Year
    -14.65% down
    Over 3 Months
    12.37% down
    Over 3 Years
    11.20% down
    Over 6 Months
    10.92% down
    Over 5 Years
    10.88% down

    POLY MEDICURE LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    18 Sep 2025 3.5 Final 18 Sep 2025 Equity shares
    19 Sep 2024 3.0 Final 20 Sep 2024 Equity shares
    21 Sep 2023 3.0 Final 22 Sep 2023 Equity shares
    16 Sep 2022 2.5 Final 19 Sep 2022 Equity shares
    16 Sep 2021 2.5 Final 17 Sep 2021 Equity shares
    27 Feb 2020 2.0 Interim 29 Feb 2020 Equity shares
    13 Sep 2019 2.0 Final 17 Sep 2019 Equity shares
    18 Sep 2018 2.0 Final 20 Sep 2018 Equity shares
    20 Sep 2017 0.5 Final 22 Sep 2017 Equity shares
    15 Feb 2017 1.0 Interim 2 16 Feb 2017 Equity shares
    11 Nov 2016 1.0 Interim 15 Nov 2016 Equity shares
    19 Sep 2016 0.5 Final 21 Sep 2016 Equity shares
    17 Mar 2016 2.5 Interim 18 Mar 2016 Equity shares
    18 Sep 2015 2.5 Final 22 Sep 2015 Equity shares
    15 Sep 2014 4.0 Final 17 Sep 2014 Equity shares
    19 Sep 2013 2.0 Final 23 Sep 2013 Equity shares
    13 Sep 2012 3.0 Final 17 Sep 2012 Equity shares
    25 Aug 2011 3.0 Final 27 Aug 2011 Equity shares
    24 Aug 2010 2.5 Final 26 Aug 2010 Equity shares
    21 Aug 2009 2.5 Final 25 Aug 2009 Equity shares
    23 Aug 2007 2.5 Final 27 Aug 2007 Equity shares
    06 Sep 2005 0.0 Final 09 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    28 Mar 2017 24 Mar 2017 1:1
    10 Jul 2013 09 Jul 2013 1:1
    29 Mar 2010 26 Mar 2010 1:1
    Ex-Date Old FV NEW FV Record Date
    02 Feb 2015 10.0 5.0 03 Feb 2015
    Dividend date Dividend amount Dividend type Record date Instrument type
    18 Sep 2025 3.5 Final 18 Sep 2025 Equity shares
    19 Sep 2024 3.0 Final 20 Sep 2024 Equity shares
    21 Sep 2023 3.0 Final 22 Sep 2023 Equity shares
    16 Sep 2022 2.5 Final 19 Sep 2022 Equity shares
    16 Sep 2021 2.5 Final 17 Sep 2021 Equity shares
    27 Feb 2020 2.0 Interim 29 Feb 2020 Equity shares
    13 Sep 2019 2.0 Final 17 Sep 2019 Equity shares
    18 Sep 2018 2.0 Final 20 Sep 2018 Equity shares
    20 Sep 2017 0.5 Final 22 Sep 2017 Equity shares
    15 Feb 2017 1.0 Interim 2 16 Feb 2017 Equity shares
    11 Nov 2016 1.0 Interim 15 Nov 2016 Equity shares
    19 Sep 2016 0.5 Final 21 Sep 2016 Equity shares
    17 Mar 2016 2.5 Interim 18 Mar 2016 Equity shares
    18 Sep 2015 2.5 Final 22 Sep 2015 Equity shares
    15 Sep 2014 4.0 Final 17 Sep 2014 Equity shares
    19 Sep 2013 2.0 Final 23 Sep 2013 Equity shares
    13 Sep 2012 3.0 Final 17 Sep 2012 Equity shares
    25 Aug 2011 3.0 Final 27 Aug 2011 Equity shares
    24 Aug 2010 2.5 Final 26 Aug 2010 Equity shares
    21 Aug 2009 2.5 Final 25 Aug 2009 Equity shares
    23 Aug 2007 2.5 Final 27 Aug 2007 Equity shares
    06 Sep 2005 0.0 Final 09 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    28 Mar 2017 24 Mar 2017 1:1
    10 Jul 2013 09 Jul 2013 1:1
    29 Mar 2010 26 Mar 2010 1:1
    Ex-Date Old FV NEW FV Record Date
    02 Feb 2015 10.0 5.0 03 Feb 2015

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Poly Medicure Ltd?

    Answer Field

    Poly Medicure Ltd share price is for NSE ₹ 1,667.60 & for BSE ₹ 1,665.40 as on Jul 28 2026 11:37 AM.

    What is the Market Cap of Poly Medicure Ltd Share?

    Answer Field

    The market cap of Poly Medicure Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 28 2026 11:37 AM.

    What is the 52 Week High and Low of Poly Medicure Ltd?

    Answer Field

    The 52 Week High and Low of Poly Medicure Ltd for NSE is ₹ 2,144.90 and ₹ 1,182.00 and for BSE is ₹ 2,143.60 and ₹ 1,184.00.

    What is 1 year return for Poly Medicure Ltd?

    Answer Field

    The 1 year returns on the stock has been -14.65%.

    What is the P/E Ratio of Poly Medicure Ltd Share?

    Answer Field

    As on Jul 28 2026 11:37 AM the price-to-earnings (PE) ratio for Poly Medicure Ltd share is 50.67.

    What is the PB ratio of Poly Medicure Ltd Share?

    Answer Field

    As on Jul 28 2026 11:37 AM, the price-to-book (PB) ratio for Poly Medicure Ltd share is 301.17.

    How to Buy Poly Medicure Ltd Share?

    Answer Field

    You can trade in Poly Medicure Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Poly Medicure Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Poly Medicure Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Poly Medicure Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |